Cargando…

Early Detection of Immune-Mediated Hypophysitis With Use of Checkpoint Inhibitor Immunotherapy

Hypophysitis is the inflammation of the pituitary gland with varying effects on hormone function that may be present secondary to the use of certain medications, infections, systemic inflammatory disorders, and other etiologies. Immunotherapy-related hypophysitis is a rare phenomenon. However, it re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yossef, Kristena, Naidoo, Shiva F, Lai, William, Levaka Veera, Raghava Reddy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119666/ https://www.ncbi.nlm.nih.gov/pubmed/35602802 http://dx.doi.org/10.7759/cureus.24291

Ejemplares similares

LBODP071 Early Detection Of Immune-mediated Hypophysitis With Use Of Checkpoint Inhibitor Immunotherapy
por: Lai, William, et al.
Publicado: (2022)

Immunotherapy-Induced Anterior Hypophysitis
por: Pachika, Pranali S, et al.
Publicado: (2021)

Rare Adverse Events Related to Nivolumab, an Immune Checkpoint Inhibitor: A Case Series
por: Ganta, Nagapratap, et al.
Publicado: (2022)

Neurosarcoidosis-Induced Hypophysitis Mimicking Pituitary Macroadenoma
por: Ach, Taïeb, et al.
Publicado: (2023)

Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event
por: Doodnauth, Andrew V, et al.
Publicado: (2021)

Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis
por: Balti, Eric, et al.
Publicado: (2022)

A Rare Case of Ipilimumab-induced Reversible Hypophysitis and Permanent Primary Hypothyroidism
por: Erra, Amani, et al.
Publicado: (2019)

Lymphocytic Hypophysitis in a Patient With Suspected Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
por: Thomas, Jamie, et al.
Publicado: (2022)

Nivolumab Induced Adrenal Insufficiency: Rare Side-effect of a New Anti-cancer Therapy - Immune-checkpoint Inhibitors
por: Rai, Maitreyee, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Induced Endocrine Adverse Events in Cancer Patients at a Tertiary Care Center in Saudi Arabia
por: Alqahtani, Ali, et al.
Publicado: (2023)

A Tale of Immune-Related Adverse Events With Sequential Trials of Checkpoint Inhibitors in a Patient With Metastatic Renal Cell Carcinoma
por: Singh, Vinit, et al.
Publicado: (2020)

Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report
por: Hayakawa, Guy, et al.
Publicado: (2023)

Ipilimumab (Immune Checkpoint Inhibitors) Hypophysitis
por: Stagnetto, Margot, et al.
Publicado: (2020)

A Case of Immune Checkpoint Inhibitor Induced Autoimmune Diabetes
por: Thambuluru, Sirisha Reddy
Publicado: (2021)

Immune Checkpoint Inhibitor Therapy Associated Hypophysitis
por: Mahzari, Moeber, et al.
Publicado: (2015)

Gastric Angiomyolipoma, a Very Rare Cause of Upper Gastrointestinal Bleeding: A Case Report and a Brief Review of Literature
por: Veera, Raghava Reddy Levaka, et al.
Publicado: (2012)

Osteoporosis Can Be the Sole Presentation in Celiac Disease
por: Bommu, Veera Jayasree Latha, et al.
Publicado: (2021)

Diabetic Ketoacidosis: An Adverse Reaction to Immunotherapy
por: Keerty, Dinesh, et al.
Publicado: (2020)

Monitoring Endocrine Complications of Immunotherapy: A Screening Tool
por: Majety, Priyanka, et al.
Publicado: (2022)

Recurrence of Hypophysitis After Immune Checkpoint Inhibitor Rechallenge
por: Park, Benjamin C, et al.
Publicado: (2022)

Progress and Challenges of Immune Checkpoint Inhibitor-Induced Hypophysitis
por: Chen, Piaohong, et al.
Publicado: (2023)

A Case of Abdominal Pain and Diarrhea Post Immunotherapy: Hypophysitis Associated with Immune Checkpoint Inhibitors
por: Alok, Akankcha, et al.
Publicado: (2022)

THU353 Late Onset Of Immune Checkpoint Inhibitor-Related Diabetes After 3 Years
por: Avula, Sreekant, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor Associated Type 1 Diabetes
por: Duenas, Jose Andres, et al.
Publicado: (2021)

Early Presentation of a Rare Complication of Sodium-Glucose Cotransporter-2 Inhibitors 10 Days After Initiation: Case Report and Literature Review
por: Elshimy, Ghada, et al.
Publicado: (2019)

Characterizing Immune Checkpoint Inhibitor-Induced Hypophysitis and Obstacles in Diagnosis
por: Johnson, Jake, et al.
Publicado: (2021)

A Rare Case of Immune-Mediated Primary Adrenal Insufficiency With Cytotoxic T-Lymphocyte Antigen-4 Inhibitor Ipilimumab in Metastatic Melanoma of Lung and Neck of Unknown Primary
por: Gaballa, Salem, et al.
Publicado: (2020)

Early Screening Strategies for Diabetes Mellitus by Leveraging Dental Visits Using Optimal Screening Tools Available Onsite
por: Mirza, Wasique, et al.
Publicado: (2018)

Thyroid Storm and Type 1 Diabetes Mellitus Induced by Combined Ipilimumab and Nivolumab Immunotherapy: A Case Report
por: Ramburuth, Vivek, et al.
Publicado: (2023)

Identifying State-Wide Health Disparities in Diabetes Mellitus Management in Arizona: Review of Healthy People 2020 Performance
por: Urban, Katelyn, et al.
Publicado: (2021)

Frequency and clinical characteristics of hypophysitis and hypopituitarism in patients undergoing immunotherapy – A systematic review
por: Jacques, Juliana Prudêncio, et al.
Publicado: (2023)

Doege-Potter Syndrome and Pierre-Marie-Bamberger Syndrome in a Patient With Pleural Solitary Fibrous Tumor: A Rare Case With Literature Review
por: Solsi, Anup, et al.
Publicado: (2020)

OR18-05 Interleukin 21 Drives The Development Of Autoimmune Diabetes Mellitus During Immune Checkpoint Inhibitor Cancer Therapy
por: Garcia Ortega, Jessica Rachel, et al.
Publicado: (2023)

Dexmethylphenidate-Induced Rhabdomyolysis by Interaction With Aromatase Inhibitor
por: Huang, Derrick, et al.
Publicado: (2022)

Review of the Literature on Ocular Complications Associated With Aromatase Inhibitor Use
por: Almafreji, Ibrahim, et al.
Publicado: (2021)

SUN-170 Development of Type 1 Diabetes Mellitus on Immune Checkpoint Inhibitor
por: Tsuei, Jessica, et al.
Publicado: (2019)

Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population
por: Wei, Khor Zhong, et al.
Publicado: (2019)

SUN-298 Spectrum of Imaging in Immune Checkpoint Inhibitor Induced Hypophysitis
por: Quandt, Zoe, et al.
Publicado: (2020)

Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns
por: Nguyen, Ha, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function
por: Jessel, Shlomit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m9vr87omkq4es871k6ujml83jp